免疫血液学の世界市場2016-2020

◆英語タイトル:Global Immunohematology Market 2016-2020
◆商品コード:IRTNTR10548
◆発行会社(調査会社):Technavio
◆発行日:2016年9月28日
◆ページ数:99
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、免疫血液学の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、免疫血液学の世界市場規模及び予測、用途別分析、製品別分析、需要先別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About Immunohematology
Blood loss or anemia can lead to chronic health problems; therefore, clinicians performs blood transfusion that can help to get relief from chronic health problems. To transfuse, blood clinicians or hospitals take blood units present in their own integrated blood banks or from other centers. Immunohematology, also commonly known as blood banking, helps to screen the donor blood components for blood antigens, Rh factor, plasma, and white blood cell components. It helps to reduce blood transfusion-related diseases such as HIV and thalassemia. According to the guidelines by World Health Organization (WHO), donated blood is screened before it is transfused to protect the people from such fatalities in most of the countries.

Technavio’s analysts forecast the global immunohematology market to grow at a CAGR of 4.79% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global immunohematology market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various immunohematology analyzers, systems, and reagents, which are used for transfusion medicine in blood banks and hospitals to screen the blood for molecular typing and serological test.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Immunohematology Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Bio-Rad Laboratories
• Grifols
• Immucor
• Ortho Clinical Diagnostics

[Other prominent vendors]
• Agena Bioscience
• BD
• Beckman Coulter
• biosurfit SA
• Cardinal Health
• DIAGAST
• Hemo bioscience
• Institut de Biotechnologies Jacques Boy
• Lorne Laboratories
• MTC INVITRO
• Reagens
• Seqirus
• Tulip
• Quotient

[Market driver]
• Growing demand for blood banks and its potential to increase sales
• For a full, detailed list, view our report

[Market challenge]
• High maintenance cost and less reimbursement of blood components
• For a full, detailed list, view our report

[Market trend]
• Paradigm shift toward molecular immunohematology
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Serologic test and its limitation

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• Global immunohematology market by analyzers and systems
• Global immunohematology market by reagents

PART 07: Market segmentation by applications
• Blood-related diseases
• HIV
• Hepatitis

PART 08: Market segmentation by end-users
• Hospitals
• Blood banks
• Diagnostic laboratories

PART 09: Geographical segmentation
• Immunohematology market in Americas
• Immunohematology market in EMEA
• Immunohematology market in APAC

PART 10: Market drivers
• Paradigm shift of end-users toward automated immunohematology analyzer
• Growing demand for blood banks and its potential to increase sales
• Increasing sales through service-oriented sales organizations and GPOs

PART 11: Impact of drivers

PART 12: Market challenges
• High maintenance cost and less reimbursement of blood components
• Decrease in blood donors and medical guidelines reducing the sales of immunohematology analyzers
• Operational challenge in blood screening and transfusion

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Increasing public and private funding to establish blood banks
• Paradigm shift toward molecular immunohematology
• Striving market growth through education and training program

PART 15: Vendor landscape
• Competitive landscape analysis
• Geographic presence: Key vendor analysis
• Market share analysis
• Bio-Rad Laboratories
• Grifols
• Immucor
• Ortho Clinical Diagnostics
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Blood collection and transfusion by hospital services in US 2014
Exhibit 03: Accredited cord blood bank of AABB in various countries
Exhibit 04: Market overview: Global immunohematology market
Exhibit 05: Impact assessment of global immunohematology market 2015
Exhibit 06: Global immunohematology market 2015-2020 ($ billions)
Exhibit 07: Blood products sold in Finland in 2012-2014
Exhibit 08: Global immunohematology market scenarios: Revenue forecast 2015 and 2020 ($ billions)
Exhibit 09: Five forces analysis
Exhibit 10: Global immunohematology market by product 2015 and 2020 ($ millions)
Exhibit 11: Market overview: Global immunohematology market by analyzers and system
Exhibit 12: Immunohematology analyzer and system market in 2015-2020 ($ billions)
Exhibit 13: Market overview: Global immunohematology market by reagents
Exhibit 14: Immunohematology reagents market in 2015-2020 ($ millions)
Exhibit 15: Prevalence of cord blood transplantation for cancerous and non-cancerous blood diseases in 2014
Exhibit 16: Market overview: Blood-related diseases in global immunohematology market
Exhibit 17: Market overview: HIV in global immunohematology market
Exhibit 18: Global immunohematology market by end-users 2015
Exhibit 19: Americas: Country-specific market impact by hospitals
Exhibit 20: EMEA: Country-specific market impact by hospitals
Exhibit 21: APAC: Country-specific market impact by hospitals
Exhibit 22: Americas: Country-specific market impact by blood banks
Exhibit 23: EMEA: Country-specific market impact by blood banks
Exhibit 24: APAC: Country-specific market impact by blood banks
Exhibit 25: Transfusion of blood in different medical segments and their usage percentage in Singapore 2016
Exhibit 26: Global immunohematology market by geographical segmentation: 2015 and 2020 ($ millions)
Exhibit 27: Geographical segmentation of global immunohematology market by market share 2015-2020
Exhibit 28: Americas: Market overview of immunohematology
Exhibit 29: Americas: Prevalence of blood-borne infections 2013-2014
Exhibit 30: Immunohematology market in Americas 2015-2020 ($ millions)
Exhibit 31: Immunohematology market in Americas: Metric analysis for various countries
Exhibit 32: Key takeaway: Immunohematology market in US
Exhibit 33: EMEA: Market overview of immunohematology
Exhibit 34: Number of blood transfusions performed in Europe in 2014 (millions)
Exhibit 35: Immunohematology market in Europe 2015-2020 ($ millions)
Exhibit 36: Immunohematology market in EMEA: Metric analysis for various countries
Exhibit 37: Key takeaway: Immunohematology market in UK
Exhibit 38: APAC: Market overview of immunohematology
Exhibit 39: Immunohematology market in APAC 2015-2020 ($ millions)
Exhibit 40: Immunohematology market in APAC: Metric analysis for various countries
Exhibit 41: Key takeaway: Immunohematology market in China
Exhibit 42: Market impact: Fully automated immunohematology analyzer based on end-users
Exhibit 43: Potential market revenue of immunohematology with estimated number of cord blood units sold worldwide
Exhibit 44: Sales strategies of distributors and companies
Exhibit 45: Impact of drivers
Exhibit 46: Cost of cord blood unit maintenance in private and public blood banks
Exhibit 47: Impact of drivers and challenges
Exhibit 48: Blood banks: Public-private partnership
Exhibit 49: Blood banks: Market impact
Exhibit 50: Companies focusing on immunohematology training to promote marketing and sales
Exhibit 51: Competitive structure analysis of global immunohematology market 2015
Exhibit 52: Competitive landscape analysis of global immunohematology market 2015
Exhibit 53: Global immunohematology market: Market share analysis of vendors 2015
Exhibit 54: Bio-Rad Laboratories: Profile summary
Exhibit 55: Bio-Rad Laboratories: Strength analysis
Exhibit 56: Bio-Rad Laboratories: Growth strategy matrix
Exhibit 57: Bio-Rad Laboratories: Opportunity assessment
Exhibit 58: Grifols: Profile summary
Exhibit 59: Grifols: Strength analysis
Exhibit 60: Grifols: Growth strategy matrix
Exhibit 61: Grifols: Opportunity assessment
Exhibit 62: Immucor: Profile summary
Exhibit 63: Immucor: Strength analysis
Exhibit 64: Immucor: Growth strategy matrix
Exhibit 65: Immucor: Opportunity assessment
Exhibit 66: Ortho Clinical Diagnostics: Profile summary
Exhibit 67: Ortho Clinical Diagnostics: Strength analysis
Exhibit 68: Ortho Clinical Diagnostics: Growth strategy matrix
Exhibit 69: Ortho Clinical Diagnostics: Opportunity assessment
Exhibit 70: Other prominent vendors



【掲載企業】

Bio-Rad Laboratories, Grifols, Immucor, Ortho Clinical Diagnostics, Agena Bioscience, BD, Beckman Coulter, biosurfit SA, Cardinal Health, DIAGAST, Hemo bioscience, Institut de Biotechnologies Jacques Boy, Lorne Laboratories, MTC INVITRO, Reagens, Seqirus, Tulip, and Quotient.

【レポートのキーワード】

免疫血液学分析装置、免疫血液学試薬、血液、HIV、病院、血液バンク

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[免疫血液学の世界市場2016-2020]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月04日現在 219,162 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆